<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Exp Clin Cancer Res</journal-id><journal-title>Journal of Experimental &#x00026; Clinical Cancer Research : CR</journal-title><issn pub-type="ppub">0392-9078</issn><issn pub-type="epub">1756-9966</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">19175942</article-id><article-id pub-id-type="pmc">2655271</article-id><article-id pub-id-type="publisher-id">1756-9966-28-12</article-id><article-id pub-id-type="doi">10.1186/1756-9966-28-12</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>The biological effect of <sup>125</sup>I seed continuous low dose rate irradiation in CL187 cells</article-title></title-group><contrib-group><contrib id="A1" contrib-type="author"><name><surname>Zhuang</surname><given-names>Hong-Qing</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>hongqingzh@163.com</email></contrib><contrib id="A2" corresp="yes" contrib-type="author"><name><surname>Wang</surname><given-names>Jun-Jie</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>doctorwangjunjie@yahoo.com.cn</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Liao</surname><given-names>An-Yan</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>liaoanyan323@126.com</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Wang</surname><given-names>Ji-Dong</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>jidongwzs@163.com</email></contrib><contrib id="A5" contrib-type="author"><name><surname>Zhao</surname><given-names>Yong</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>zhaoy@ioz.ac.cn</email></contrib></contrib-group><aff id="I1"><label>1</label>Cancer Center, Department of Radiation Oncology, Peking University Third Hospital, Beijing 100191, PR China</aff><aff id="I2"><label>2</label>Transplantation Biology Research Division, State Key Laboratory of Biomembrane and Membrane Biotechnology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, PR China</aff><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>29</day><month>1</month><year>2009</year></pub-date><volume>28</volume><issue>1</issue><fpage>12</fpage><lpage>12</lpage><ext-link ext-link-type="uri" xlink:href="http://www.jeccr.com/content/28/1/12"/><history><date date-type="received"><day>27</day><month>11</month><year>2008</year></date><date date-type="accepted"><day>29</day><month>1</month><year>2009</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2009 Zhuang et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2009</copyright-year><copyright-holder>Zhuang et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author>
               Zhuang
               Hong-Qing
               
               hongqingzh@163.com
            </dc:author><dc:title>
            The biological effect of 125I seed continuous low dose rate irradiation in CL187 cells
         </dc:title><dc:date>2009</dc:date><dcterms:bibliographicCitation>Journal of Experimental &#x00026; Clinical Cancer Research 28(1): 12-. (2009)</dcterms:bibliographicCitation><dc:identifier type="sici">1756-9966(2009)28:1&#x0003c;12&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1756-9966</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Background</title><p>To investigate the effectiveness and mechanism of <sup>125</sup>I seed continuous low-dose-rate irradiation on colonic cell line CL187 in vitro.</p></sec><sec sec-type="methods"><title>Methods</title><p>The CL187 cell line was exposed to radiation of <sup>60</sup>Co&#x003b3; ray at high dose rate of 2 Gy/min and <sup>125</sup>I seed at low dose rate of 2.77 cGy/h. Radiation responses to different doses and dose rates were evaluated by colony-forming assay. Under <sup>125</sup>I seed low dose rate irradiation, a total of 12 culture dishes were randomly divided into 4 groups: Control group, and 2, 5, and 10 Gy irradiation groups. At 48 h after irradiation, apoptosis was detected by Annexin and Propidium iodide (PI) staining. Cell cycle arrests were detected by PI staining. In order to investigate the influence of low dose rate irradiation on the MAPK signal transduction, the expression changes of epidermal growth factor receptor (EGFR) and Raf under continuous low dose rate irradiation (CLDR) and/or EGFR monoclonal antibodies were determined by indirect immunofluorescence.</p></sec><sec><title>Results</title><p>The relative biological effect (RBE) for <sup>125</sup>I seeds compared with <sup>60</sup>Co &#x003b3; ray was 1.41. Apoptosis rates of CL187 cancer cells were 13.74% &#x000b1; 1.63%, 32.58% &#x000b1; 3.61%, and 46.27% &#x000b1; 3.82% after 2 Gy, 5 Gy, and 10 Gy irradiation, respectively; however, the control group apoptosis rate was 1.67% &#x000b1; 0.19%. G<sub>2</sub>/M cell cycle arrests of CL187 cancer cells were 42.59% &#x000b1; 3.21%, 59.84% &#x000b1; 4.96%, and 34.61% &#x000b1; 2.79% after 2 Gy, 5 Gy, and 10 Gy irradiation, respectively; however, the control group apoptosis rate was 26.44% &#x000b1; 2.53%. <italic>P </italic>&#x0003c; 0.05 vs. control groups by Student's t-test were found in every treated group both in apoptosis and in G<sub>2</sub>/M cell cycle arrest. After low dose rate irradiation, EGFR and Raf expression increased, but when EGFR was blocked by a monoclonal antibody, EGFR and Raf expression did not change.</p></sec><sec><title>Conclusion</title><p><sup>125</sup>I seeds resulted in more effective inhibition than <sup>60</sup>Co &#x003b3; ray high dose rate irradiation in CL187 cells. Apoptosis following G<sub>2</sub>/M cell cycle arrest was the main mechanism of cell-killing effects under low dose rate irradiation. CLDR could influence the proliferation of cells via MAPK signal transduction.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>Because of its ability to offer high precision, little trauma, strong lethality, and fewer complications [<xref ref-type="bibr" rid="B1">1</xref>-<xref ref-type="bibr" rid="B4">4</xref>], <sup>125</sup>I radioactive seed implantation has been widely applied in clinical practice for tumor treatment, such as prostate carcinoma [<xref ref-type="bibr" rid="B5">5</xref>], recurrent colorectal cancer [<xref ref-type="bibr" rid="B6">6</xref>-<xref ref-type="bibr" rid="B10">10</xref>], head and neck carcinoma [<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B12">12</xref>], and others [<xref ref-type="bibr" rid="B13">13</xref>-<xref ref-type="bibr" rid="B15">15</xref>]. However, radiobiological study of continuous low dose rate irradiation (CLDR), and especially that which defines the deep development of radioactive seed implantation and its intersection with other subjects of tumor treatment, has only recently been conducted [<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B17">17</xref>]. Therefore, further study on the basic radiobiology of continuous low dose rate irradiation is necessary, particularly to provide further clinical direction. In the present study, the CL187 colonic cell line was exposed to <sup>125</sup>I seeds at low dose rate irradiation, and killing effect of cells cultured in vitro were observed to reveal the radiobilogical mechanism of <sup>125</sup>I radioactive seed irradiation.</p></sec><sec sec-type="materials|methods"><title>Materials and methods</title><sec><title>Reagents</title><p>Cell culture media was provided by the Zoology Institute of the Chinese Academy of Sciences. Propidium iodide (PI) and annexin V were purchased from Cell Signaling Company (Cell Signaling Technology, Beverly, MA). Phospho-P38 epidermal growth factor receptor (EGFR) mAb (Alexa Fluor) and Phospho-raf mAb (Alexa Fluor) were obtained from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). All other materials were obtained from the Zoology Institute of the Chinese Academy of Sciences.</p></sec><sec><title>Cell lines and cell culture</title><p>The CL187 colonic cancer cell line was kindly provided by the Beijing Institute for Cancer Research. It was maintained in RPMI1640 supplemented with 20 mM HEPES (pH 7.4), 100 IU/mL penicillin, 100 mg/mL streptomycin, 4 mM glutamine, and 10% heat-inactivated fetal bovine serum (Hangzhou Sijiqing Biological Engineering Materials Company, China) in a humidified atmosphere of 95% air and 5% CO2 at 37&#x000b0;C.</p></sec><sec><title><sup>125</sup>I seeds irradiation</title><p>We used our in-house developed in vitro iodine-125 seed irradiation model shown in Figure <xref ref-type="fig" rid="F1">1</xref>[<xref ref-type="bibr" rid="B18">18</xref>]. The model consists of a 3-mm thick polystyrene panel, with a lower seed plaque layer and an upper cell culture plaque layer. In the seed plaque, 14 seeds with the same activity were equally spaced within recesses (4.5 mm &#x000d7; 0.8 mm) around a 35-mm diameter (D) circumference. In the cell culture plaque, the same recesses were made around a 35-mm D circumference; its center was along the same vertical line as that of the seed plaque, so that a 35-mm Petri dish could be placed on it during the experiment. The height (H) between the seed plaque and the bottom of Petri dish was 12 mm, with a D/H ratio of 2.9. The purpose of this design was to obtain a relatively homogeneous dose distribution at the bottom of the Petri dish. The polystyrene assembly was enclosed by a 3-mm thick lead chamber with a vent-hole, so that during the study the whole model could be kept in the incubator. The incubator played a protective role by maintaining constant cell culture conditions. Model 6711 <sup>125</sup>I seeds were provided by Ningbo Junan Pharmaceutical Technology Company, China. The single seed activity used in this study was 92.5 MBq (2.5 mCi), corresponding initial dose rate in model cells was 2.77 cGy/h. The dose uniformity of the irradiation model in the cell plane was 1.34, which was similar to other investigators' results [<xref ref-type="bibr" rid="B2">2</xref>]. The model was validated using thermoluminescent dosimetry (TLD) measurement. The absorbed dose for different exposure time in various culture planes has also been measured and verified. The exposure time for delivering doses of 100, 200, 400, 600, 800 and 1000 cGy are 36, 73.7, 154.6, 245.8, 345.1, 460.1 hours. Exponentially-growing CL187 cells in a tissue-culture flask (35 mm diameter) were irradiated using the above model. The cells were subsequently incubated for another 21 d at constant temperature and humidity. Irradiation was performed at the Zoology Institute of the Chinese Academy of Sciences.</p><fig position="float" id="F1"><label>Figure 1</label><caption><p><bold><sup>125</sup>I seed experiment irradiation pattern in vitro</bold>.</p></caption><graphic xlink:href="1756-9966-28-12-1"/></fig></sec><sec><title>Clonogenic survival</title><p>Clonogenic survival was defined as the ability of cells to maintain clonogenic capacity and to form colonies. Briefly, cells in the control and irradiation groups were exposed to different radiation dosages (0, 1, 2, 4, 6, 8, and 10 Gy). After incubation for 21 d, colonies were stained with crystal violet and manually counted. The plating efficiency (PE) and survival fraction (SF) were calculated as follows: PE = (colony number/inoculating cell number) &#x000d7; 100%. SF = PE (tested group)/PE (0-Gy group) &#x000d7; 100%. A dose-survival curve was obtained for each experiment and used for calculating several survival parameters. Parallel samples were set at each irradiation dosage. The cell-survival curve was plotted with Origin 7.5 software, using the equation: SF = 1 - (1 - e<sup>-D/D0</sup>)<sup>N</sup>. The multi-target, single-hit model was applied to calculate cellular radiosensitivity (mean lethal dose, D<sub>0</sub>), capacity for sublethal damage repair (quasithreshold dose, Dq), and extrapolation number (N). The D<sub>10</sub>values were used to calculate the relative biological effect (RBE).</p></sec><sec><title>Cell cycle and apoptosis analysis</title><p>Cells from the control and CLDR-treated groups were exposed to different radiation dosages (0, 2, 5, and 10 Gy). Cells were harvested 48 h after irradiation. For detection of apoptotic cells, cells were trypsinized, acridine orange stained, and determined under fluorescence microscope. At the same time, cells were counted and washed twice with cold PBS. Cells used for apoptosis tests were stained with propidium iodide (PI) and annexin V for 15 min in the dark. Cells used for cell-cycle testing were stained with propidium iodide after ethanol fixation and analyzed by fluorescence-activated cell sorting (FACS) using Coulter EPICS and ModFit software (Verity Software House, Topsham, MN). Each test was performed 3 times [<xref ref-type="bibr" rid="B19">19</xref>].</p></sec><sec><title>EGFR and Raf quantifications by FCM</title><p>Control and treated CL187 cells for EGFR and Raf quantifications by FCM were harvested 24 h after 4 Gy irradiation. Each test was performed 3 times. Cells used for tests were stained with Phospho-P38 EGFR mAb (Alexa Fluor) and Phospho-raf mAb (Alexa Fluor), and then analyzed by FACScan using Coulter EPICS and ModFit software. Each test was performed 3 times [<xref ref-type="bibr" rid="B20">20</xref>-<xref ref-type="bibr" rid="B22">22</xref>].</p></sec><sec><title>Statistical analysis</title><p>Data were plotted as means &#x000b1; standard deviation. Student's t test was used for comparisons. Differences were considered significant at P &#x0003c; 0.05.</p></sec></sec><sec><title>Results</title><sec><title>Survival curve of CL187 cells after different dose rate irradiation</title><p>Data showed that cell-killing effects were related to dose rate. The survival curve of CL187 cells after different dose rate irradiation is shown in Figure <xref ref-type="fig" rid="F2">2</xref>. At the same dose, the survival fractions of <sup>125</sup>I seeds were always lower than <sup>60</sup>Co &#x003b3; ray (Table <xref ref-type="table" rid="T1">1</xref>). The cloning efficiency of CL187 was between 70% and 90%. Radiobiological parameters of high dose rate irradiation treated CL187 cells were D<sub>0 </sub>= 1.85, Dq = 0.35, and N = 1.55, while those of <sup>125</sup>I seed low dose rate irradiation cells were D<sub>0 </sub>= 1.32, Dq = 0.14, and N = 1.28. In the present study, RBE = D<sub>10 </sub><sup>60</sup>Co/D<sub>10</sub><sup>125</sup>I = 4.23/3.01 = 1.41. The data presented herein suggested that the biological effect of <sup>125</sup>I seed irradiation was stronger than that of <sup>60</sup>Co &#x003b3; ray (t = 2.578, <italic>P </italic>&#x0003c; 0.05).</p><fig position="float" id="F2"><label>Figure 2</label><caption><p><bold>Dose-survival curves of CL187 cells after high and low dose rate irradiation</bold>.</p></caption><graphic xlink:href="1756-9966-28-12-2"/></fig><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Survival fraction of different dose rate irradiation in CL187 cell line (%, <inline-formula><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M1" name="1756-9966-28-12-i1" overflow="scroll"><mml:semantics><mml:mover accent="true"><mml:mi>x</mml:mi><mml:mo>&#x000af;</mml:mo></mml:mover></mml:semantics></mml:math></inline-formula> &#x000b1; s)</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="center" colspan="6">Irradiation dose (Gy)</td></tr><tr><td></td><td colspan="6"><hr></hr></td></tr><tr><td></td><td align="center">1</td><td align="center">2</td><td align="center">4</td><td align="center">6</td><td align="center">8</td><td align="center">10</td></tr><tr><td align="center" colspan="7">Survival fraction</td></tr></thead><tbody><tr><td align="left"><sup>60</sup>Co</td><td align="center">73 &#x000b1; 22</td><td align="center">49 &#x000b1; 11</td><td align="center">17 &#x000b1; 5.2</td><td align="center">5.7 &#x000b1; 2.1</td><td align="center">1.8 &#x000b1; 0.19</td><td align="center">0.74 &#x000b1; 0.21</td></tr><tr><td align="left"><sup>125</sup>I</td><td align="center">55 &#x000b1; 18<sup>a</sup></td><td align="center">28 &#x000b1; 10<sup>b</sup></td><td align="center">5.2 &#x000b1; 2.7<sup>c</sup></td><td align="center">1.3 &#x000b1; 0.25<sup>d</sup></td><td align="center">0.33 &#x000b1; 0.12<sup>e</sup></td><td align="center">0.08 &#x000b1; 0.03<sup>f</sup></td></tr></tbody></table><table-wrap-foot><p>Compared with <sup>60</sup>Co group, t = 8.03, <sup>a</sup>P &#x0003c; 0.05; t = 4.85, <sup>b</sup>P &#x0003c; 0.05; t = 13.69, <sup>c</sup>P &#x0003c; 0.01; t = 11.43, <sup>d</sup>P &#x0003c; 0.01; t = 4.76, <sup>e</sup>P &#x0003c; 0.05; and t = 4.62, <sup>f</sup>P &#x0003c; 0.05.</p></table-wrap-foot></table-wrap></sec><sec><title>Low dose rate irradiation-induced apoptosis and cell cycle arrest</title><p>Cells were stained by acridine orange and observed under fluorescence microscopy; typical morphological features of apoptotic cells appeared after 5 Gy low dose rate irradiation (Fig. <xref ref-type="fig" rid="F3">3</xref>). FCM analysis showed that under low dose rate irradiation, apoptosis and G<sub>2</sub>/M cell cycle arrest increased slightly at 2 Gy, the peak appeared at 5 Gy, and the ratio was also high at 10 Gy (Table <xref ref-type="table" rid="T2">2</xref>) but lower than that at 5 Gy. Furthermore, G<sub>2</sub>/M cell cycle arrest and apoptosis walked together along with the dose change (r = 0.918, <italic>P </italic>&#x0003c; 0.01, Fig. <xref ref-type="fig" rid="F4">4</xref>). Quantitative measurements of apoptotic cell death by FCM in CL187 cells sufficiently indicated that apoptosis is an important mechanism of low dose rate irradiation inhibition of CL187 cell proliferation.</p><fig position="float" id="F3"><label>Figure 3</label><caption><p><bold>Apoptosis of <sup>125</sup>I low dose rate irradiation-treated CL187 cells</bold>. CL187 cells were stained with acridine orange, and determined under fluorescence microscope. There were no apoptotic cells in control groups (A), but typical morphological features of apoptosis appeared after 5 Gy CLDR irradiation (B). The apoptotic rates were detected by flow cytometry. In 2 Gy (D), 5 Gy (E), and 10 Gy (F) groups, the CL187 cells had higher apoptosis rates when compared with control groups (C). Concrete data see table <xref ref-type="table" rid="T3">3</xref>. One of three experiments is shown. <italic>P </italic>&#x0003c; 0.05 vs. control group were found in every treated groups.</p></caption><graphic xlink:href="1756-9966-28-12-3"/></fig><fig position="float" id="F4"><label>Figure 4</label><caption><p><bold>Effect of <sup>125</sup>I low dose rate irradiation on the cell cycle in CL187 cells</bold>. Flow cytometry analysis revealed that the G<sub>2</sub>/M phase increased by 2 Gy (B)<sup>125I </sup>irradiation dose as compared with untreated control cells (A). After 5 Gy irradiation (C), a sharp increase in the fraction of cells in the G<sub>2</sub>/M phase was observed. The result in 10 Gy irradiation groups (D) was lower than that in group C, but sustained at a relatively high level. Compared with untreated control cells, <italic>P </italic>&#x0003c; 0.05 were found in all of the treated groups.</p></caption><graphic xlink:href="1756-9966-28-12-4"/></fig><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Apoptosis index and cell cycle distribution after <sup>125</sup>I low dose rate irradiation (%, <inline-formula><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M2" name="1756-9966-28-12-i1" overflow="scroll"><mml:semantics><mml:mover accent="true"><mml:mi>x</mml:mi><mml:mo>&#x000af;</mml:mo></mml:mover></mml:semantics></mml:math></inline-formula> &#x000b1; s).</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="left">Apoptosis</td><td align="left">G<sub>0</sub>/G<sub>1</sub></td><td align="left">S</td><td align="left">G<sub>2</sub>/M</td></tr></thead><tbody><tr><td align="left">Control</td><td align="left">1.67 &#x000b1; 0.19</td><td align="left">64.94 &#x000b1; 5.87</td><td align="left">8.62 &#x000b1; 0.59</td><td align="left">26.44 &#x000b1; 2.53</td></tr><tr><td align="left">2 Gy</td><td align="left">13.74 &#x000b1; 1.63<sup>a</sup></td><td align="left">54.14 &#x000b1; 3.16</td><td align="left">11.25 &#x000b1; 1.34</td><td align="left">34.61 &#x000b1; 2.79<sup>d</sup></td></tr><tr><td align="left">5 Gy</td><td align="left">46.27 &#x000b1; 3.82<sup>b</sup></td><td align="left">26.60 &#x000b1; 2.82</td><td align="left">13.56 &#x000b1; 1.68</td><td align="left">59.84 &#x000b1; 4.96<sup>e</sup></td></tr><tr><td align="left">10 Gy</td><td align="left">32.58 &#x000b1; 3.61<sup>c</sup></td><td align="left">41.69 &#x000b1; 4.58</td><td align="left">15.72 &#x000b1; 2.29</td><td align="left">42.59 &#x000b1; 3.21<sup>f</sup></td></tr></tbody></table><table-wrap-foot><p>Compared with control group (apoptosis), t = 8.377, <sup>a</sup>P &#x0003c; 0.05; t = 36.44, <sup>b</sup>P &#x0003c; 0.01; and t = 27.35, <sup>c</sup>P &#x0003c; 0.01. Compared with control group (G<sub>2</sub>/M arrests), t = 30.81, <sup>d</sup>P &#x0003c; 0.05; t = 23.98, <sup>d</sup>P &#x0003c; 0.05; and t = 26.3, <sup>e</sup>P &#x0003c; 0.05.</p></table-wrap-foot></table-wrap></sec><sec><title>Expression changes of EGFR and Raf in CL187 cells after irradiation and/or EGFR monoclonal antibody treatment</title><p>Under low dose rate irradiation, expression of EGFR (74.27 &#x000b1; 5.63%) and Raf (53.84 &#x000b1; 2.31%) was significantly higher than in the control group (Fig. <xref ref-type="fig" rid="F5">5</xref> and Table <xref ref-type="table" rid="T3">3</xref>). After signal transduction was blocked, expression of EGFR (2.07 &#x000b1; 0.31%) and Raf (13.74 &#x000b1; 1.82%) did not show detectable change after low dose rate irradiation (Fig. <xref ref-type="fig" rid="F5">5</xref> and Table <xref ref-type="table" rid="T3">3</xref>).</p><fig position="float" id="F5"><label>Figure 5</label><caption><p><bold>EGFR and Raf expression changes in CL187 cells after <sup>125</sup>I irradiation and/or Anti-EGFR mAb</bold>. CLDR could influence the proliferation of cells via MAPK signal transduction. One representive of two experiments is shown.</p></caption><graphic xlink:href="1756-9966-28-12-5"/></fig><table-wrap position="float" id="T3"><label>Table 3</label><caption><p>Expression changes of EGFR and Raf in CL187 cells after irradiation and/or EGFR monoclonal antibody treatment (%, <inline-formula><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M3" name="1756-9966-28-12-i1" overflow="scroll"><mml:semantics><mml:mover accent="true"><mml:mi>x</mml:mi><mml:mo>&#x000af;</mml:mo></mml:mover></mml:semantics></mml:math></inline-formula> &#x000b1; s).</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="left">EGFR</td><td align="left">Raf</td></tr></thead><tbody><tr><td align="left">Control</td><td align="left">45.36 &#x000b1; 3.91</td><td align="left">39.57 &#x000b1; 3.48</td></tr><tr><td colspan="3"><hr></hr></td></tr><tr><td align="left"><sup>125</sup>I irradiation</td><td align="left">74.27 &#x000b1; 5.63<sup>a</sup></td><td align="left">53.84 &#x000b1; 2.31<sup>d</sup></td></tr><tr><td align="left">Anti-EGFR mAb</td><td align="left">2.31 &#x000b1; 0.19<sup>b</sup></td><td align="left">14.68 &#x000b1; 1.35<sup>e</sup></td></tr><tr><td align="left"><sup>125</sup>I irradiation + Anti-EGFR mAb</td><td align="left">2.27 &#x000b1; 0.13<sup>c</sup></td><td align="left">13.74 &#x000b1; 1.82<sup>f</sup></td></tr></tbody></table><table-wrap-foot><p>Compared with control group (EGFR), t = 54.84, <sup>a</sup>P &#x0003c; 0.01; t = 27.38, <sup>b</sup>P &#x0003c; 0.05. Compared with anti-EGFR mAb group (EGFR), t = 1.21, <sup>c</sup>P &#x0003e; 0.05. Compared with control group (Raf), t = 46.66, <sup>d</sup>P &#x0003c; 0.01; and t = 26.60, <sup>e</sup>P &#x0003c; 0.01. Compared with anti-EGFR mAb group (Raf), t = 0.98, <sup>f</sup>P &#x0003e; 0.05.</p></table-wrap-foot></table-wrap></sec></sec><sec><title>Discussion</title><p>Low-energy radioactive seed interstitial implantation has resulted in positive clinical treatment of many tumors previously radioresistant to high dose rate irradiation. This may be due to different radiobiological mechanisms between low and high dose rate irradiation. Nevertheless, compared with springing up of radioactive seeds interstitial implantation, fundamental research on this topic is notably absent, and the radiobiological mechanism of <sup>125</sup>I seed low dose rate irradiation remains unclear.</p><p>As classic methods of appraising killing efficacy of irradiation, cell proliferation and clonic assays were used in the experiment. High dose rate irradiation killed tumor cells, but simultaneously induced radioresistance. However, the dose survival curve of <sup>125</sup>I seed continuous low dose rate irradiation had no significant shoulder region, and SF was lower than <sup>60</sup>Co &#x003b3; ray high dose rate irradiation. From the radiobiological parameter results, we also observed that <sup>125</sup>I continuous low dose rate irradiation showed great advantages relative to high dose rate irradiation. Although RBE could be affected by many factors, such as cell line and dose rate, most studies have shown that the RBE of <sup>125</sup>I was between 1.3 and 1.5. The present results are consistent with previous reports [<xref ref-type="bibr" rid="B24">24</xref>-<xref ref-type="bibr" rid="B27">27</xref>].</p><p>Our results indicated that apoptosis may play a central role regarding the observed killing effects when cells were exposed to <sup>125</sup>I seed low dose rate irradiation [<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B29">29</xref>]. Prior studies have suggested that radiosensitivity is cell cycle dependent, and cells in the G<sub>2</sub>/M phase could be more radioresponsive [<xref ref-type="bibr" rid="B30">30</xref>]. These results suggest that CLDR may enhance radiosensitivity by inducing accumulation of cells in a more radiosensitive cell cycle phase (G<sub>2</sub>/M) [<xref ref-type="bibr" rid="B31">31</xref>,<xref ref-type="bibr" rid="B32">32</xref>]. The apoptosis index of 10 Gy was lower than that of 5 Gy; two possibilities for this occurrence are: (a) Early-apoptotic cells disintegrated within the exposure time of 10 Gy, and could not be detected by FCM; and (b) Low dose rate irradiation only delayed the cell cycle, but could not completely block the cell cycle. Overshoot early irradiation, cells changed to be more radioresistant. Therefore, the apoptotic cells under 10 Gy were fewer than those under 5 Gy. Similarly, G<sub>2</sub>/M arrest also declined under 10 Gy [<xref ref-type="bibr" rid="B33">33</xref>].</p><p>Our results indicated that the up-regulation of Raf expression correlated well with an increase in the level of EGFR expression after <sup>125</sup>I seed irradiation [<xref ref-type="bibr" rid="B34">34</xref>-<xref ref-type="bibr" rid="B37">37</xref>]. It is suggested that the expression changes were all induced by CLDR. It is essential to prove that CLDR functioned via MAPK signal transduction. When the signal transduction was blocked by the EGFR monoclonal antibody, no obvious change in Raf expression occurred after <sup>125</sup>I seed irradiation. It was proved that the necessary conditions were also sufficient [<xref ref-type="bibr" rid="B38">38</xref>,<xref ref-type="bibr" rid="B39">39</xref>]. These results formed the basis for combining CLDR with EGFR tyrosine kinase inhibitors in clinical practice [<xref ref-type="bibr" rid="B40">40</xref>,<xref ref-type="bibr" rid="B41">41</xref>,<xref ref-type="bibr" rid="B22">22</xref>].</p><p>In summary, our study provides a beneficial exploration of radiobiology of continuous low dose rate irradiation. Although many issues remain to be addressed, we believe that, with further development of fundamental research, application of <sup>125</sup>I radioactive seed implantation in clinical practice will continue to be improved.</p></sec><sec><title>Abbreviations</title><p>LDR: low-dose rate; HDR: high-dose rate; SLD: sublethal damage; SSB: single strand breaks; DSB: double strand breaks; ATM: ataxia-telangiectasia mutated; NHEJ: nonhomologous end joining; HR: homologous recombination; HRS: hyper-radiosensitivity; RBE: relative biological effectiveness; PE: plating efficiency; SF: survival fraction; CLDR: continuous low-dose-rate; EGFR: epidermal growth factor receptor.</p></sec><sec><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><sec><title>Authors' contributions</title><p>HQZ carried out cell colony-forming assay, fluorescence-activated cell sorting, flow cytometric analysis, and drafted the manuscript. JJW participated in its design and revised the manuscript. AYL performed the statistical analysis. JDW carried out the irradiation experiment. YZ supervised experimental work and revised the manuscript. All authors read and approved the final manuscript.</p></sec></body><back><ack><sec><title>Acknowledgements</title><p>The authors wish to thank Dr. Rui-jie Yang and Dong-Mei Tian for their critical reading of the manuscript, Ms. Jing Wang and Ms. Jian-Xia Peng for their expert technical assistance and Ms. Qing-Huan Li for her excellent laboratory management. This work was supported by a grant from the Ministry of Civil Affair, China ([2007]18).</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nath</surname><given-names>R</given-names></name><name><surname>Anderson</surname><given-names>LL</given-names></name><name><surname>Luxton</surname><given-names>G</given-names></name><name><surname>Weaver</surname><given-names>KA</given-names></name><name><surname>Williamson</surname><given-names>JF</given-names></name><name><surname>Meigooni</surname><given-names>AS</given-names></name></person-group><article-title>Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43</article-title><source>Med Phys</source><year>1995</year><volume>22</volume><issue>2</issue><fpage>209</fpage><lpage>234</lpage><pub-id pub-id-type="pmid">7565352</pub-id><pub-id pub-id-type="doi">10.1118/1.597458</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aird</surname><given-names>EG</given-names></name><name><surname>Folkard</surname><given-names>M</given-names></name><name><surname>Mayes</surname><given-names>CR</given-names></name><name><surname>Bownes</surname><given-names>PJ</given-names></name><name><surname>Lawson</surname><given-names>JM</given-names></name><name><surname>Joiner</surname><given-names>MC</given-names></name></person-group><article-title>A purpose built iodine-125 plaque for low dose rate low energy irradiation of cell lines in vitro</article-title><source>Br J Radiol</source><year>2001</year><volume>74</volume><issue>877</issue><fpage>56</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">11227778</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reniers</surname><given-names>B</given-names></name><name><surname>Vynckier</surname><given-names>S</given-names></name><name><surname>Verhaegen</surname><given-names>F</given-names></name></person-group><article-title>Theoretical analysis of microdosimetric spectra and cluster formation for Pd-103 and I-125 photon emitters</article-title><source>Int J Radiat Oncol Biol Phys</source><year>2004</year><volume>49</volume><issue>16</issue><fpage>3781</fpage><lpage>3795</lpage></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Yue</surname><given-names>N</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Roberts</surname><given-names>KB</given-names></name><name><surname>Peschel</surname><given-names>R</given-names></name><name><surname>Nath</surname><given-names>R</given-names></name></person-group><article-title>Dosimetric effects of edema in permanent prostate seed implants: a rigorous solution</article-title><source>Int J Radiat Oncol Biol Phys</source><year>2000</year><volume>47</volume><issue>5</issue><fpage>1405</fpage><lpage>1419</lpage><pub-id pub-id-type="pmid">10889396</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>Y</given-names></name><name><surname>Anderson</surname><given-names>LL</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Mellenberg</surname><given-names>DE</given-names></name><name><surname>Nath</surname><given-names>R</given-names></name><name><surname>Schell</surname><given-names>MC</given-names></name><name><surname>Waterman</surname><given-names>FM</given-names></name><name><surname>Wu</surname><given-names>A</given-names></name><name><surname>Blasko</surname><given-names>JC</given-names></name></person-group><article-title>Permanent prostate seed implant brachytherapy: report of the American Association of Physicists in Medicine Task Group No. 64</article-title><source>Med Phys</source><year>1999</year><volume>26</volume><issue>10</issue><fpage>2054</fpage><lpage>2076</lpage><pub-id pub-id-type="pmid">10535622</pub-id><pub-id pub-id-type="doi">10.1118/1.598721</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Yuan</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Jiang</surname><given-names>W</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Tian</surname><given-names>S</given-names></name></person-group><article-title>Interstitial permanent implantation of <sup>125</sup>I seeds as salvage therapy for re-recurrent rectal carcinoma</article-title><source>Int J Colorectal Dis</source><year>2009</year><volume>24</volume><issue>4</issue><fpage>391</fpage><lpage>399</lpage><comment></comment><pub-id pub-id-type="pmid">19084969</pub-id><pub-id pub-id-type="doi">10.1007/s00384-008-0628-4</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koutrouvelis</surname><given-names>PG</given-names></name></person-group><article-title>Computed tomography-guided salvage brachytherapy of recurrent large nonresectable familial colo-rectal cancer in the pelvis: case report</article-title><source>Technol Cancer Res Treat</source><year>2002</year><volume>1</volume><issue>1</issue><fpage>61</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">12614178</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sakurai</surname><given-names>H</given-names></name><name><surname>Mitsuhashi</surname><given-names>N</given-names></name><name><surname>Harashima</surname><given-names>K</given-names></name><name><surname>Muramatsu</surname><given-names>H</given-names></name><name><surname>Ishikawa</surname><given-names>H</given-names></name><name><surname>Kitamoto</surname><given-names>Y</given-names></name><name><surname>Suzuki</surname><given-names>Y</given-names></name><name><surname>Saitoh</surname><given-names>JI</given-names></name><name><surname>Nonaka</surname><given-names>T</given-names></name><name><surname>Akimoto</surname><given-names>T</given-names></name><name><surname>Nakayama</surname><given-names>Y</given-names></name><name><surname>Hasegawa</surname><given-names>M</given-names></name><name><surname>Nakano</surname><given-names>T</given-names></name></person-group><article-title>CT-fluoroscopy guided interstitial brachytherapy with image-based treatment planning for unresectable locally recurrent rectal carcinoma</article-title><source>Brachytherapy</source><year>2004</year><volume>3</volume><issue>4</issue><fpage>222</fpage><lpage>230</lpage><pub-id pub-id-type="pmid">15607154</pub-id><pub-id pub-id-type="doi">10.1016/j.brachy.2004.09.007</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mart&#x000ed;nez-Monge</surname><given-names>R</given-names></name><name><surname>Nag</surname><given-names>S</given-names></name><name><surname>Martin</surname><given-names>EW</given-names></name></person-group><article-title>Three different intraoperative radiation modalities (electron beam, high-dose-rate brachytherapy, and iodine-125 brachytherapy) in the adjuvant treatment of patients with recurrent colorectal adenocarcinoma</article-title><source>Cancer</source><year>1999</year><volume>86</volume><issue>2</issue><fpage>236</fpage><lpage>247</lpage><pub-id pub-id-type="pmid">10421259</pub-id><pub-id pub-id-type="doi">10.1002/(SICI)1097-0142(19990715)86:2&#x0003c;236::AID-CNCR7&#x0003e;3.0.CO;2-9</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Coatmeur</surname><given-names>O</given-names></name><name><surname>Truc</surname><given-names>G</given-names></name><name><surname>Barillot</surname><given-names>I</given-names></name><name><surname>Horiot</surname><given-names>JC</given-names></name><name><surname>Maingon</surname><given-names>P</given-names></name></person-group><article-title>Treatment of T1&#x02013;T2 rectal tumors by contact therapy and interstitial brachytherapy</article-title><source>Radiother Oncol</source><year>2004</year><volume>70</volume><issue>2</issue><fpage>177</fpage><lpage>182</lpage><pub-id pub-id-type="pmid">15028405</pub-id><pub-id pub-id-type="doi">10.1016/j.radonc.2004.01.016</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Yuan</surname><given-names>H</given-names></name><name><surname>Ran</surname><given-names>W</given-names></name></person-group><article-title>Implantation of iodine-125 seed for head and neck carcinoma</article-title><source>Chin J Radiol Med Prot</source><year>2006</year><volume>26</volume><issue>1</issue><fpage>56</fpage><lpage>59</lpage></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Conill</surname><given-names>C</given-names></name><name><surname>Verger</surname><given-names>E</given-names></name><name><surname>Marruecos</surname><given-names>J</given-names></name><name><surname>Vargas</surname><given-names>M</given-names></name><name><surname>Biete</surname><given-names>A</given-names></name></person-group><article-title>Low dose rate brachytherapy in lip carcinoma</article-title><source>Clin Transl Oncol</source><year>2007</year><volume>9</volume><issue>4</issue><fpage>251</fpage><lpage>254</lpage><pub-id pub-id-type="pmid">17462978</pub-id><pub-id pub-id-type="doi">10.1007/s12094-007-0046-z</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Joyce</surname><given-names>F</given-names></name><name><surname>Burcharth</surname><given-names>F</given-names></name><name><surname>Holm</surname><given-names>HH</given-names></name><name><surname>Stroyer</surname><given-names>I</given-names></name></person-group><article-title>Ultrasonically guided percutaneous implantation of iodine-125 seeds in pancreatic carcinoma</article-title><source>Int J Radiat Oncol Biol Phys</source><year>1990</year><volume>19</volume><issue>4</issue><fpage>1049</fpage><lpage>1052</lpage><pub-id pub-id-type="pmid">1698755</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Montemaggi</surname><given-names>P</given-names></name><name><surname>Dobelbower</surname><given-names>R</given-names></name><name><surname>Crucitti</surname><given-names>F</given-names></name><name><surname>Caracciolo</surname><given-names>F</given-names></name><name><surname>Morganti</surname><given-names>AG</given-names></name><name><surname>Smaniotto</surname><given-names>D</given-names></name><name><surname>Luzi</surname><given-names>S</given-names></name><name><surname>Cellini</surname><given-names>N</given-names></name></person-group><article-title>Interstitial brachytherapy for pancreatic cancer: report of seven cases treated with 125I and a review of the literature</article-title><source>Int J Radiat Oncol Biol Phys</source><year>1991</year><volume>21</volume><fpage>451</fpage><lpage>457</lpage><pub-id pub-id-type="pmid">2061121</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>J</given-names></name><name><surname>Bruckner</surname><given-names>H</given-names></name></person-group><article-title>Adjuvant and Neoadjuvant Therapies of Pancreatic Cancer: A Review</article-title><source>Int J Gastrointest Cancer</source><year>2001</year><volume>29</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">12754399</pub-id><pub-id pub-id-type="doi">10.1385/IJGC:29:1:01</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nath</surname><given-names>R</given-names></name><name><surname>Bongiorni</surname><given-names>P</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Gragnano</surname><given-names>J</given-names></name><name><surname>Rochwell</surname><given-names>S</given-names></name></person-group><article-title>Development of a rat solid tumor modal for continuous low-dose-rate irradiation studies using 125I and 103Pd sources</article-title><source>Brachytherapy</source><year>2004</year><volume>3</volume><issue>3</issue><fpage>159</fpage><lpage>172</lpage><pub-id pub-id-type="pmid">15533809</pub-id><pub-id pub-id-type="doi">10.1016/j.brachy.2004.08.004</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mirzaie-Joniani</surname><given-names>H</given-names></name><name><surname>Eriksson</surname><given-names>D</given-names></name><name><surname>Sheikholvaezin</surname><given-names>A</given-names></name><name><surname>Johansson</surname><given-names>A</given-names></name><name><surname>Lofroth</surname><given-names>PO</given-names></name><name><surname>Johansson</surname><given-names>L</given-names></name><name><surname>Stigbrand</surname><given-names>T</given-names></name></person-group><article-title>Apoptosis induced by low-dose-rate radiation</article-title><source>Cancer</source><volume>94</volume><issue>4 Suppl</issue><fpage>1210</fpage><lpage>1214</lpage><pub-id pub-id-type="pmid">11877747</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Zhuang</surname><given-names>H</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Liao</surname><given-names>A</given-names></name></person-group><article-title>Development and validation of radioactive iodine-125 irradiator in vitro</article-title><source>Chin J Radiol Med Protect</source><year>2007</year><volume>27</volume><issue>3</issue><fpage>267</fpage><lpage>271</lpage></citation></ref><ref id="B19"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Sambrook</surname><given-names>J</given-names></name><name><surname>David</surname><given-names>R</given-names></name></person-group><source>Molecular Cloning</source><year>2000</year><edition>Third</edition><publisher-name>America: CSHL Press</publisher-name><fpage>1235</fpage><lpage>1262</lpage></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>V&#x000e1;vrov&#x000e1;</surname><given-names>J</given-names></name><name><surname>Rez&#x000e1;cov&#x000e1;</surname><given-names>M</given-names></name><name><surname>Vokurkov&#x000e1;</surname><given-names>D</given-names></name><name><surname>Psutka</surname><given-names>J</given-names></name></person-group><article-title>Cell cycle alteration, apoptosis and response of leukemic cell lines to gamma radiation with high- and low-dose rate</article-title><source>Physiol Res</source><year>2004</year><volume>53</volume><issue>3</issue><fpage>335</fpage><lpage>342</lpage><pub-id pub-id-type="pmid">15209542</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chinnaiyan</surname><given-names>P</given-names></name><name><surname>Huang</surname><given-names>S</given-names></name><name><surname>Vallabhaneni</surname><given-names>G</given-names></name><name><surname>Armstrong</surname><given-names>E</given-names></name><name><surname>Varambally</surname><given-names>S</given-names></name><name><surname>Tomlins</surname><given-names>SA</given-names></name><name><surname>Chinnaiyan</surname><given-names>AM</given-names></name><name><surname>Harari</surname><given-names>PM</given-names></name></person-group><article-title>Mechanisms of Enhanced Radiation Response following EpidermalGrowth Factor Receptor Signaling Inhibition by Erlotinib (Tarceva)</article-title><source>Cancer Res</source><year>2005</year><volume>65</volume><issue>8</issue><fpage>3328</fpage><lpage>3335</lpage><pub-id pub-id-type="pmid">15833866</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ciardiello</surname><given-names>F</given-names></name><name><surname>Tortora</surname><given-names>G</given-names></name></person-group><article-title>EGFR Antagonists in Cancer Treatment</article-title><source>N Engl J Med</source><year>2008</year><volume>358</volume><fpage>1160</fpage><lpage>1174</lpage><pub-id pub-id-type="pmid">18337605</pub-id><pub-id pub-id-type="doi">10.1056/NEJMra0707704</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Harari</surname><given-names>PM</given-names></name><name><surname>Allen</surname><given-names>GW</given-names></name><name><surname>Bonner</surname><given-names>JA</given-names></name></person-group><article-title>Biology of interactions: antiepidermal growth factor receptor agents</article-title><source>J Clin Oncol</source><year>2007</year><volume>25</volume><issue>26</issue><fpage>4057</fpage><lpage>4065</lpage><pub-id pub-id-type="pmid">17827454</pub-id><pub-id pub-id-type="doi">10.1200/JCO.2007.11.8984</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lehnert</surname><given-names>S</given-names></name><name><surname>Reniers</surname><given-names>B</given-names></name><name><surname>Verhaegen</surname><given-names>F</given-names></name></person-group><article-title>Relative biologic effectiveness in terms of tumor response of <sup>125</sup>I implants compared with <sup>60</sup>Co gamma rays</article-title><source>Int J Radiat Oncol Biol Phys</source><year>2005</year><volume>63</volume><issue>1</issue><fpage>224</fpage><lpage>229</lpage><pub-id pub-id-type="pmid">16111593</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nath</surname><given-names>R</given-names></name><name><surname>Bongiorni</surname><given-names>P</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Gragnano</surname><given-names>J</given-names></name><name><surname>Rockwell</surname><given-names>S</given-names></name></person-group><article-title>Relative biological effectiveness of 103Pd and 125I photons for continuous low-dose-rate irradiation of Chinese hamster cells</article-title><source>Radiat Res</source><year>2005</year><volume>163</volume><issue>5</issue><fpage>501</fpage><lpage>509</lpage><pub-id pub-id-type="pmid">15850411</pub-id><pub-id pub-id-type="doi">10.1667/RR3363</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Taschereau</surname><given-names>R</given-names></name><name><surname>Roy</surname><given-names>R</given-names></name><name><surname>Pouliot</surname><given-names>J</given-names></name></person-group><article-title>Relative biological effectiveness enhancement of a 125I brachytherapy seed with characteristic X rays from its constitutive materials</article-title><source>Med Phys</source><year>2002</year><volume>29</volume><issue>7</issue><fpage>1397</fpage><lpage>1402</lpage><pub-id pub-id-type="pmid">12148718</pub-id><pub-id pub-id-type="doi">10.1118/1.1485054</pub-id></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wuu</surname><given-names>CS</given-names></name><name><surname>Kliauga</surname><given-names>P</given-names></name><name><surname>Zaider</surname><given-names>M</given-names></name><name><surname>Amols</surname><given-names>HI</given-names></name></person-group><article-title>Microdosimetric evaluation of relative biological effectiveness for 103Pd, 125I, 241Am, and 192Ir brachytherapy sources</article-title><source>Int J Radiat Oncol Biol Phys</source><year>1996</year><volume>36</volume><issue>3</issue><fpage>689</fpage><lpage>697</lpage><pub-id pub-id-type="pmid">8948355</pub-id></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Short</surname><given-names>SC</given-names></name><name><surname>Mitchell</surname><given-names>SA</given-names></name><name><surname>Boulton</surname><given-names>P</given-names></name><name><surname>Woodcock</surname><given-names>M</given-names></name><name><surname>Joiner</surname><given-names>MC</given-names></name></person-group><article-title>The response of human glioma cell lines to low-dose radiation exposure</article-title><source>Int J Radiat Biol</source><year>1999</year><volume>75</volume><issue>11</issue><fpage>1341</fpage><lpage>1348</lpage><pub-id pub-id-type="pmid">10597908</pub-id><pub-id pub-id-type="doi">10.1080/095530099139214</pub-id></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mirzaie-Joniani</surname><given-names>H</given-names></name><name><surname>Eriksson</surname><given-names>D</given-names></name><name><surname>Johansson</surname><given-names>A</given-names></name><name><surname>Lofroth</surname><given-names>PO</given-names></name><name><surname>Johansson</surname><given-names>L</given-names></name><name><surname>Ahlstrom</surname><given-names>KR</given-names></name><name><surname>Stigbrand</surname><given-names>T</given-names></name></person-group><article-title>Apoptosis in HeLa Hep2 cells is induced by low-dose, low-dose-rate radiation</article-title><source>Radiat Res</source><year>2002</year><volume>158</volume><issue>5</issue><fpage>634</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">12385641</pub-id><pub-id pub-id-type="doi">10.1667/0033-7587(2002)158[0634:AIHHCI]2.0.CO;2</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>CR</given-names></name><name><surname>Joiner</surname><given-names>MC</given-names></name></person-group><article-title>Effect of subsequent acute-dose irradiation on cell survival in vitro following low dose-rate exposures</article-title><source>Int J Radiat Biol</source><year>2002</year><volume>78</volume><issue>11</issue><fpage>981</fpage><lpage>990</lpage><pub-id pub-id-type="pmid">12456285</pub-id><pub-id pub-id-type="doi">10.1080/0955300021006589</pub-id></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Collis</surname><given-names>SJ</given-names></name><name><surname>Schwaninger</surname><given-names>JM</given-names></name><name><surname>Ntambi</surname><given-names>AJ</given-names></name><name><surname>Keller</surname><given-names>TW</given-names></name><name><surname>Nelson</surname><given-names>WG</given-names></name><name><surname>Dillehay</surname><given-names>LE</given-names></name><name><surname>Deweese</surname><given-names>TL</given-names></name></person-group><article-title>Evasion of early cellular response mechanisms following low level radiation-induced DNA damage</article-title><source>J Biol Chem</source><year>2004</year><volume>279</volume><issue>48</issue><fpage>49624</fpage><lpage>49632</lpage><pub-id pub-id-type="pmid">15377658</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M409600200</pub-id></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>H</given-names></name><name><surname>Yasui</surname><given-names>Y</given-names></name><name><surname>Saito</surname><given-names>N</given-names></name><name><surname>Tachibana</surname><given-names>A</given-names></name><name><surname>Komatsu</surname><given-names>K</given-names></name><name><surname>Ishizaki</surname><given-names>K</given-names></name></person-group><article-title>DNA repair defect in AT cells and their hypersensitivity to low-dose-rate radiation</article-title><source>Radiat Res</source><year>2006</year><volume>165</volume><issue>3</issue><fpage>277</fpage><lpage>282</lpage><pub-id pub-id-type="pmid">16494515</pub-id><pub-id pub-id-type="doi">10.1667/RR3519.1</pub-id></citation></ref><ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carlsson</surname><given-names>J</given-names></name><name><surname>H&#x000e5;kansson</surname><given-names>E</given-names></name><name><surname>Eriksson</surname><given-names>V</given-names></name><name><surname>Grawe</surname><given-names>J</given-names></name><name><surname>Wester</surname><given-names>K</given-names></name><name><surname>Grusell</surname><given-names>E</given-names></name><name><surname>Montelius</surname><given-names>A</given-names></name><name><surname>Lundqvist</surname><given-names>H</given-names></name></person-group><article-title>Early effect of low dose-rate radiation on cultured tumor cells</article-title><source>Cancer Biother Radiopharm</source><year>2003</year><volume>18</volume><issue>4</issue><fpage>663</fpage><lpage>670</lpage><pub-id pub-id-type="pmid">14503962</pub-id><pub-id pub-id-type="doi">10.1089/108497803322287754</pub-id></citation></ref><ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kroger</surname><given-names>LA</given-names></name><name><surname>DeNardo</surname><given-names>GL</given-names></name><name><surname>Gumerlock</surname><given-names>PH</given-names></name><name><surname>Xiong</surname><given-names>CY</given-names></name><name><surname>Winthrop</surname><given-names>MD</given-names></name><name><surname>Shi</surname><given-names>XB</given-names></name><name><surname>Mack</surname><given-names>PC</given-names></name><name><surname>Leshchinsky</surname><given-names>T</given-names></name></person-group><article-title>Apoptosis-ralated gene and protein expression in human lymphoma xenografts after low dose rate radiation using 67Cu-21T-BAT-Lym-1</article-title><source>Cancer Biother Radiopharm</source><year>2004</year><volume>16</volume><issue>3</issue><fpage>213</fpage><lpage>225</lpage><pub-id pub-id-type="pmid">11471486</pub-id><pub-id pub-id-type="doi">10.1089/10849780152389401</pub-id></citation></ref><ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>KC</given-names></name><name><surname>Knox</surname><given-names>WF</given-names></name><name><surname>Gandhi</surname><given-names>A</given-names></name><name><surname>Slamon</surname><given-names>DJ</given-names></name><name><surname>Potten</surname><given-names>CS</given-names></name><name><surname>Bundred</surname><given-names>NJ</given-names></name></person-group><article-title>Blockade of growth factor receptors in ductal carcinoma in situ inhibits epithelial proliferation</article-title><source>Br J Surg</source><year>2001</year><volume>88</volume><issue>3</issue><fpage>412</fpage><lpage>418</lpage><pub-id pub-id-type="pmid">11260109</pub-id><pub-id pub-id-type="doi">10.1046/j.1365-2168.2001.01686.x</pub-id></citation></ref><ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ciardiello</surname><given-names>F</given-names></name><name><surname>Caputo</surname><given-names>R</given-names></name><name><surname>Troiani</surname><given-names>T</given-names></name><name><surname>Borriello</surname><given-names>G</given-names></name><name><surname>Kandimalla</surname><given-names>ER</given-names></name><name><surname>Agrawal</surname><given-names>S</given-names></name><name><surname>Mendelsohn</surname><given-names>J</given-names></name><name><surname>Bianco</surname><given-names>AR</given-names></name><name><surname>Tortora</surname><given-names>G</given-names></name></person-group><article-title>Antisense oligonucleotides targeting the epidermal growth factor receptor inhibit proliferation, induce apoptosis, and cooperate with cytotoxic drugs in human cancer cell lines</article-title><source>Int J Cancer</source><year>2001</year><volume>93</volume><issue>2</issue><fpage>172</fpage><lpage>178</lpage><pub-id pub-id-type="pmid">11410862</pub-id><pub-id pub-id-type="doi">10.1002/ijc.1335</pub-id></citation></ref><ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baker</surname><given-names>CH</given-names></name><name><surname>Kedar</surname><given-names>D</given-names></name><name><surname>McCarty</surname><given-names>MF</given-names></name><etal></etal></person-group><article-title>Blockade of epidermal growth factor receptor signaling on tumor cells and tumor-associated endothelial cells for therapy of human carcinomas</article-title><source>Am J Pathol</source><year>2002</year><volume>161</volume><fpage>929</fpage><lpage>938</lpage><pub-id pub-id-type="pmid">12213721</pub-id></citation></ref><ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lammering</surname><given-names>G</given-names></name><name><surname>Valerie</surname><given-names>K</given-names></name><name><surname>Lin</surname><given-names>PS</given-names></name><name><surname>Mikkelsen</surname><given-names>RB</given-names></name><name><surname>Contessa</surname><given-names>JN</given-names></name><name><surname>Feden</surname><given-names>JP</given-names></name><name><surname>Farnsworth</surname><given-names>J</given-names></name><name><surname>Dent</surname><given-names>P</given-names></name><name><surname>Schmidt-Ullrich</surname><given-names>RK</given-names></name></person-group><article-title>Radiosensitization of malignant glioma cells through overexpression of dominantnegative epidermal growth factor receptor</article-title><source>Clin Cancer Res</source><year>2001</year><volume>7</volume><issue>3</issue><fpage>682</fpage><lpage>690</lpage><pub-id pub-id-type="pmid">11297265</pub-id></citation></ref><ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lammering</surname><given-names>G</given-names></name><name><surname>Hewit</surname><given-names>TH</given-names></name><name><surname>Hawkins</surname><given-names>WT</given-names></name><name><surname>Contessa</surname><given-names>JN</given-names></name><name><surname>Reardon</surname><given-names>DB</given-names></name><name><surname>Lin</surname><given-names>PS</given-names></name><name><surname>Valerie</surname><given-names>K</given-names></name><name><surname>Dent</surname><given-names>P</given-names></name><name><surname>Kikkelsen</surname><given-names>RB</given-names></name><name><surname>Schmidt-Ullrich</surname><given-names>RK</given-names></name></person-group><article-title>Epidermal growth factor receptor as a genetic therapy target for carcinoma cell radiosensitization</article-title><source>J Natl Cancer Inst</source><year>2001</year><volume>93</volume><issue>12</issue><fpage>921</fpage><lpage>929</lpage><pub-id pub-id-type="pmid">11416113</pub-id><pub-id pub-id-type="doi">10.1093/jnci/93.12.921</pub-id></citation></ref><ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>Z</given-names></name></person-group><article-title>Targeted cancer therapies based on antibodies directed against epidermal growth factor receptor: status and perspectives</article-title><source>Acta Pharmacol Sin</source><year>2007</year><volume>28</volume><issue>9</issue><fpage>1476</fpage><lpage>1493</lpage><pub-id pub-id-type="pmid">17723181</pub-id><pub-id pub-id-type="doi">10.1111/j.1745-7254.2007.00681.x</pub-id></citation></ref><ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baselga</surname><given-names>J</given-names></name><name><surname>Cortes</surname><given-names>J</given-names></name></person-group><article-title>Epidermal growth factor receptor pathway inhibitors</article-title><source>Cancer Chemother Biol Response Modif</source><year>2005</year><volume>22</volume><fpage>205</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">16110613</pub-id></citation></ref></ref-list></back></article>


